Search Medical Condition
Please enter condition
Please choose location from dropdown

Sjukhusvagen, Sweden Clinical Trials

A listing of Sjukhusvagen, Sweden clinical trials actively recruiting patients volunteers.

RESULTS

Found (164) clinical trials

The Swedish Study of Irrigation Fluid Temperature in the Evacuation of Chronic Subdural Hematoma

The study will be a multicenter randomised controlled trial of the use of irrigation fluid of body temperature versus irrigation fluid of room temperature during burr hole evacuation of chronic subdural hematoma.

Phase N/A

0.03 miles

Learn More »

Surgical Treatment of Peri-implantitis With and Without Systemically Adjunctive Antibiotics

This study will give the opportunity to draw scientifically based conclusions on the recommendations of the use of adjunctive systemic antibiotics in the treatment of peri-implantitis. This study will also be able to determine the ecological impact on the oropharyngeal and intestinal microflora between different antibiotic treatments. The lack of ...

Phase

0.03 miles

Learn More »

Joint Coordination to Facilitate the Transition From Sick Leave to Employment

GESAM is a randomized controlled intervention study that addressed women and men on long-term sick leave in Uppsala County. Participants which are on sick leave due to mental illness and/or pain and were expected to reach the time limit within the in health insurance will be offered to participate in ...

Phase N/A

0.31 miles

Learn More »

SOMNOmedics Clinical Validation Trial

Plan to enroll patients who accept the terms of the study consecutively. The population is composed by pediatric and adult patients in anesthesia and intensive care in need of close blood pressure monitoring. After informed consent from the patients themselves, patient and parents and sometimes only parents. The device measuring ...

Phase N/A

0.31 miles

Learn More »

Uppsala Study on Odontoid Fracture Treatment in the Elderly

50 patients, based on the following calculation of study size: The standard deviation for Neck Disability index, NDI, is just under 7, while "minimally clinical important difference" (MCID) is 7 points . That gives that 16 patients are needed in each group to get 80% power with a significance level ...

Phase N/A

0.31 miles

Learn More »

Nocturnal Enuresis and Rapid Maxillary Expansion

Nocturnal enuresis (NE) is the involuntary loss of urine that occurs only at night in children aged 5 years or more. NE is a common problem, affecting about 10% of school children. The prevalence declines with each year of maturity but for some it persists in to adolescents and early ...

Phase N/A

0.38 miles

Learn More »

A Randomized Trial to Assess the Role of Imaging During Follow up After Radical Surgery of High Risk Melanoma

The patients are randomized 1:1 to routine follow up for 3 years with regular doctors appointments according to national guidelines and the same follow up but with the addition of whole body CT or Positron Emission Tomography (PET) scans and blood tests.

Phase N/A

0.57 miles

Learn More »

AZD5718 Phase IIa Study to Evaluate Efficacy Safety and Tolerability of Oral AZD5718 in Patients With Coronary Artery Disease (CAD).

This is a randomized, single-blind, placebo-controlled, parallel-group, multicentre study in patients with CAD. The study will be conducted at approximately 10 centres in 3 countries (Denmark, Finland and Sweden). Patients suitable for the study will be identified and screened for eligibility after being hospitalized for Acute Coronary Syndrome (ACS) (Visit ...

Phase

0.57 miles

Learn More »

A Study of Subcutaneous Versus (vs.) Intravenous Administration of Daratumumab in Participants With Relapsed or Refractory Multiple Myeloma

The study population will consist of adults diagnosed with multiple myeloma who have received at least 3 prior lines of therapy including a proteasome inhibitor (PI) and an immunomodulatory drug (IMiD), or whose disease is refractory to both a PI and an IMiD. The study consists of 3 phases: a ...

Phase

0.57 miles

Learn More »

HR+/HER2- Advanced Breast Cancer and Endocrine Resistance

This is a randomized, 2-arm, open-label, multicenter, international phase II trial. A total of 196 patients will be included. The study will include patients with metastatic Hormone Receptor positive / Human Epidermal Growth Factor Receptor (HER2) negative breast cancer with progressive disease after endocrine treatment. Patients will be randomized (1:1) ...

Phase

0.57 miles

Learn More »